Waiting for radiotherapy in Ontario

Mackillop, William J.; Fu, Hai; Quirt, Carol F.; Dixon, Peter; Brundage, Michael; Zhou, Yunzheng

doi:10.1016/0360-3016(94)90538-x

Cited by 136 publications

(63 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…73 Some delay to treatment problems have been described among Canadian samples, but they have not accounted for SES in any way. [74][75][76] Such problems seem to be associated with provincial or regional cancer care service endowments, rather than with personal income or other such individual factors.…”

Section: The Unifying Construct Of Health Insurance Statusmentioning

confidence: 99%

See 1 more Smart Citation

Social, Prognostic, and Therapeutic Factors Associated with Cancer Survival: A Population-Based Study in Metropolitan Detroit, Michigan

Gorey¹,

Holowaty²,

Laukkanen³

et al. 2003

hpu

View full text Add to dashboard Cite

Section: The Unifying Construct Of Health Insurance Statusmentioning

confidence: 99%

“…a All adjusted for age (25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39)(40)(41)(42)(43)(44)(45)(46)(47)(48)(49)(50)(51)(52)(53)(54)(55)(56)(57)(58)(59)(60)(61)(62)(63)(64)(65)(66)(67)(68)(69)(70)(71)(72)(73)(74)75 years or older) and other factors in the model.…”

Section: The Unifying Construct Of Health Insurance Statusmentioning

confidence: 99%

Social, Prognostic, and Therapeutic Factors Associated with Cancer Survival: A Population-Based Study in Metropolitan Detroit, Michigan

Gorey¹,

Holowaty²,

Laukkanen³

et al. 2003

hpu

View full text Add to dashboard Cite

“…However, studies have demonstrated that wait times for treatment (for example, between the decision to treat and the start of treatment) continue to be longer for men with pca than for individuals with other cancers in Canada's universal health care system [6][7][8][9][10][11] . Prolonged delays between cancer diagnosis and treatment have been associated with anxiety, stress, and perceived powerlessness for patients and their family members [12][13][14] .…”

Section: Introductionmentioning

confidence: 99%

Wait Times for Prostate Cancer Treatment and Patient Perceptions of Care in Canada: A Mixed-Methods Report

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Studies demonstrate that men with prostate cancer experience longer wait times for diagnosis and treatment than those observed for other cancers. [2][3][4][5][6] While the evidence that longer waits are associated with worse prognosis in prostate cancer is inconclusive, [7][8][9][10][11][12][13][14][15][16] it has been demonstrated that diagnostic and treatment delay are associated with patient and family psychosocial distress in this population. 17,18 The care pathway for localized prostate cancer is characterized by a sequence of events extending from suspicion …”

Section: Introductionmentioning

confidence: 99%

Wait times in prostate cancer diagnosis and radiation treatment

Stevens

Bondy

Loblaw

2013

CUAJ

View full text Add to dashboard Cite

Introduction: Wait times for cancer diagnosis and treatment area significant concern for Canadians. Men with prostate cancerexperience longer waiting times for diagnosis and treatment thanthose observed for other cancers. Longer waits are associated withboth patient and family psychosocial distress and may be associatedwith worse prognosis.Methods: Men referred for treatment of prostate cancer at a singleCanadian cancer centre were interviewed. The intervals from suspicionto definitive therapy were calculated, factors associated withdelays along this pathway were identified, and common causes ofdelay identified by patients were described.Results: A total of 41 consecutive patients participated. The medianinterval from suspicion to the first fraction of radiotherapy forall patients was 247 days (interquartile range [IQR] 168-367 d).The median diagnostic interval was 53 days (IQR 28-166 d). Themedian treatment interval was 127 days (IQR 100-180 d). Patientsunder 70 years old and patients with <T2c disease had shorterintervals from suspicion to treatment. From diagnosis to start ofradiotherapy, patients with low-risk disease had longer intervals.Seventy percent of patients perceived a delay in their care, ofwhich 45%, 31% and 24% of patients felt the delays were due tothe health care system, patient or physician factors, respectively.Interpretation: In this study, 12% and 0% of patients met CanadianStrategy for Cancer Control and Canadian Association of RadiationOncologists wait time recommendations, respectively. A large componentof wait time is patient driven. Alternate strategies shouldbe developed and measured to shorten the intervals between thesuspicion and treatment of prostate cancer.Introduction : Les temps d’attente pour recevoir un diagnosticde cancer et un traitement constituent une source importante depréoccupation pour les Canadiens. Les hommes atteints de cancerde la prostate attendent encore plus longtemps que les patientsatteints d’autres types de cancer pour obtenir un diagnostic etentreprendre un traitement. Ces attentes plus longues se traduisentpour le patient et sa famille par un stress psychosocial et peuventêtre liés à un pronostic plus sombre.Méthodologie : Des hommes aiguillés vers le même centre decancérologie au Canada pour la prise en charge d’un cancer dela prostate ont été interviewés. L’intervalle entre le soupçon decancer et le début réel du traitement a été calculé; on a cernéles facteurs liés aux retards le long du processus, et les causes deretards signalées par les patients ont été décrites.Résultats : Au total, 41 patients consécutifs ont participé. La duréemédiane de l’intervalle entre le soupçon de cancer et la premièreséance de radiothérapie pour tous les patients était de 247 jours(écart interquartile [EIQ], 168 à 367 jours). La durée médianede l’intervalle avant le diagnostic était de 53 jours (EIQ, 28 à166 jours). La durée médiane de l’intervalle avant le début dutraitement était de 127 jours (EIQ, 100 à 180 jours). Les patients deplus de 70 ans et les patients porteurs d’une tumeur T2c ou moinsavancée signalaient des intervalles plus courts entre les premierssoupçons de cancer et le traitement. Entre le diagnostic et le débutde la radiothérapie, les patients présentant une maladie à faiblerisque avaient des intervalles plus longs. Soixante-dix pour centdes patients ont perçu un retard dans leur prise en charge, parmilesquels 45 % croyaient ce retard lié au système de santé, 31 %, àdes facteurs liés au patient, et 24 %, à des facteurs liés au médecin.Interprétation : Dans cette étude, 12 % et 0 % des patients,respectivement, ont présenté des temps d’attentes conformes auxrecommandations de la Stratégie canadienne de lutte contre lecancer et de l’Association canadienne de radio-oncologie. Letemps d’attente est déterminé en grande partie par des facteurs liésau patient. D’autres stratégies devraient être élaborées et évaluéesafin de réduire les intervalles entre les premiers soupçons de cancerde la prostate et le début du traitement.

show abstract

Waiting for radiotherapy in Ontario

Cited by 136 publications

References 10 publications

Social, Prognostic, and Therapeutic Factors Associated with Cancer Survival: A Population-Based Study in Metropolitan Detroit, Michigan

Social, Prognostic, and Therapeutic Factors Associated with Cancer Survival: A Population-Based Study in Metropolitan Detroit, Michigan

Wait Times for Prostate Cancer Treatment and Patient Perceptions of Care in Canada: A Mixed-Methods Report

Wait times in prostate cancer diagnosis and radiation treatment

Contact Info

Product

Resources

About